Similarly, Metformin has also been found to enhance autophagy of mesangial cell via SIRT1 and AMPK pathways to effectively ameliorate glycolipid metabolic disorders, inflammation, MC proliferation, and extracellular matrix expression in DKD (168, 169). This evidence concerns the gene SIRT1 and diabetic kidney disease.